BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics

Rheumatology (Oxford). 2017 Feb;56(2):313-316. doi: 10.1093/rheumatology/kew223. Epub 2016 Aug 24.
No abstract available

Keywords: ankylosing spondylitis; anti-TNF; axial spondyloarthritis; biologic; guideline; treatment.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / standards*
  • Biological Products / standards*
  • Humans
  • Spondylarthritis / drug therapy*
  • Spondylitis, Ankylosing / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • United Kingdom

Substances

  • Antirheumatic Agents
  • Biological Products
  • Tumor Necrosis Factor-alpha